Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
04 Apr 2025
// REUTERS
https://www.reuters.com/business/putin-names-little-known-firm-run-pharma-company-spun-off-germanys-stada-2025-04-04/
18 Mar 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/stada-says-still-considering-all-options-after-report-delayed-ipo-2025-03-18/
28 Aug 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/germanys-stada-reports-rosy-earnings-first-half-2024-ceo-tempers-sales-rumors
22 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/22/2916396/0/en/STADA-and-Alvotech-launch-Uzpruvo-the-first-approved-ustekinumab-biosimilar-to-Stelara-across-Europe.html
12 Jun 2024
// PRESS RELEASE
https://investors.alvotech.com/news-releases/news-release-details/alvotech-and-stada-add-strategic-alliance-through-denosumab
31 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/calliditas-partner-stada-receives-positive-chmp-opinion-recommending-full-approval-for-kinpeygo-for-the-treatment-of-iga-nephropathy-302159841.html
ABOUT THIS PAGE